miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis
CE Condrat, DC Thompson, MG Barbu, OL Bugnar… - Cells, 2020 - mdpi.com
MicroRNAs (miRNAs) represent a class of small, non-coding RNAs with the main roles of
regulating mRNA through its degradation and adjusting protein levels. In recent years …
regulating mRNA through its degradation and adjusting protein levels. In recent years …
Enhancing sepsis biomarker development: key considerations from public and private perspectives
JF Llitjos, ED Carrol, MF Osuchowski, M Bonneville… - Critical Care, 2024 - Springer
Implementation of biomarkers in sepsis and septic shock in emergency situations, remains
highly challenging. This viewpoint arose from a public–private 3-day workshop aiming to …
highly challenging. This viewpoint arose from a public–private 3-day workshop aiming to …
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Systematic characterization of the cancer microbiome provides the opportunity to develop
techniques that exploit non-human, microorganism-derived molecules in the diagnosis of a …
techniques that exploit non-human, microorganism-derived molecules in the diagnosis of a …
A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
D de Gonzalo-Calvo, M Molinero, ID Benítez… - Respiratory …, 2023 - Springer
Background The identification of critically ill COVID-19 patients at risk of fatal outcomes
remains a challenge. Here, we first validated candidate microRNAs (miRNAs) as biomarkers …
remains a challenge. Here, we first validated candidate microRNAs (miRNAs) as biomarkers …
p53 and HuR combinatorially control the biphasic dynamics of microRNA-125b in response to genotoxic stress
Post-transcriptional regulation of p53, by the microRNA miR-125b and the RNA-binding
protein HuR, controls p53 expression under genotoxic stress. p53 mRNA translation is …
protein HuR, controls p53 expression under genotoxic stress. p53 mRNA translation is …
MicroRNA-30e-5p regulates SOCS1 and SOCS3 during bacterial infection
Host innate immunity is the major player against continuous microbial infection. Various
pathogenic bacteria adopt the strategies to evade the immunity and show resistance toward …
pathogenic bacteria adopt the strategies to evade the immunity and show resistance toward …
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP
The vectored Ebola vaccine rVSVΔG-ZEBOV-GP elicits protection against Ebola Virus
Disease (EVD). In a study of forty-eight healthy adult volunteers who received either the …
Disease (EVD). In a study of forty-eight healthy adult volunteers who received either the …
Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumonia
JM Galván-Román, Á Lancho-Sánchez… - PLoS …, 2020 - journals.plos.org
Introduction Patients with community-acquired pneumonia (CAP) undergo a dysregulated
host response that is related to mortality. MicroRNAs (miRNAs) participate in this response …
host response that is related to mortality. MicroRNAs (miRNAs) participate in this response …
[HTML][HTML] Identification of a novel antiviral micro-RNA targeting the NS1 protein of the H1N1 pandemic human influenza virus and a corresponding viral escape …
The influenza A virus (IAV) NS1 protein is one of the major regulators of pathogenicity, being
able to suppress innate immune response and host protein synthesis. In this study we …
able to suppress innate immune response and host protein synthesis. In this study we …
Welche Biomarker zu Diagnosestellung und Steuerung der antiinfektiven Therapie bei Sepsis?
J Ehler, C Busjahn, T Schürholz - Der Anaesthesist, 2021 - pmc.ncbi.nlm.nih.gov
Die Identifikation eines Biomarkers, der idealerweise eine perfekte Sensitivität und Spezifität
mitbringt, um eine Inflammation von einer Infektion zu unterscheiden, ist bis heute nicht …
mitbringt, um eine Inflammation von einer Infektion zu unterscheiden, ist bis heute nicht …